Neutrophilic inflammation and epithelial barrier disruption in nasal polyps characterize non-steroidal anti-inflammatory drug exacerbated respiratory disease

Allergy. 2022 Apr;77(4):1297-1299. doi: 10.1111/all.15198. Epub 2021 Dec 26.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents
  • Chronic Disease
  • Humans
  • Inflammation
  • Nasal Mucosa
  • Nasal Polyps*
  • Rhinitis*
  • Sinusitis*

Substances

  • Anti-Inflammatory Agents